These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15067065)

  • 61. Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin.
    Provoda CJ; Stier EM; Lee KD
    J Biol Chem; 2003 Sep; 278(37):35102-8. PubMed ID: 12832408
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Listeria infection modulates mitochondrial dynamics.
    Stavru F; Cossart P
    Commun Integr Biol; 2011 May; 4(3):364-6. PubMed ID: 21980582
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-Throughput Microplate-Based Assay to Monitor Plasma Membrane Wounding and Repair.
    Pathak-Sharma S; Zhang X; Lam JGT; Weisleder N; Seveau SM
    Front Cell Infect Microbiol; 2017; 7():305. PubMed ID: 28770170
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hijacking of apoptotic pathwaysby bacterial pathogens.
    Gao L; Abu Kwaik Y
    Microbes Infect; 2000 Nov; 2(14):1705-19. PubMed ID: 11137044
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Granzymes drive a rapid listeriolysin O-induced T cell apoptosis.
    Carrero JA; Vivanco-Cid H; Unanue ER
    J Immunol; 2008 Jul; 181(2):1365-74. PubMed ID: 18606691
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Listeria monocytogenes transiently alters mitochondrial dynamics during infection.
    Stavru F; Bouillaud F; Sartori A; Ricquier D; Cossart P
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3612-7. PubMed ID: 21321208
    [TBL] [Abstract][Full Text] [Related]  

  • 67.
    Hong H; Hu Y; Shi S; Liu B; Zheng W; Bo R; Xu Z; Wu Y; Cao Y
    Front Vet Sci; 2024; 11():1413523. PubMed ID: 39220769
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Roles of host SUMOylation in bacterial pathogenesis.
    Ma X; Zhao C; Xu Y; Zhang H
    Infect Immun; 2023 Oct; 91(10):e0028323. PubMed ID: 37725062
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genomic and pathogenicity islands of
    Wiktorczyk-Kapischke N; Skowron K; Wałecka-Zacharska E
    Front Mol Biosci; 2023; 10():1161486. PubMed ID: 37388250
    [No Abstract]   [Full Text] [Related]  

  • 70. Mitochondria in health, disease, and aging.
    Harrington JS; Ryter SW; Plataki M; Price DR; Choi AMK
    Physiol Rev; 2023 Oct; 103(4):2349-2422. PubMed ID: 37021870
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Kaempferol-Driven Inhibition of Listeriolysin O Pore Formation and Inflammation Suppresses Listeria monocytogenes Infection.
    Wang T; Liu B; Zhang C; Fang T; Ding Y; Song G; Zhang S; Shi L; Deng X; Wang J
    Microbiol Spectr; 2022 Aug; 10(4):e0181022. PubMed ID: 35856678
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Listeria exploits IFITM3 to suppress antibacterial activity in phagocytes.
    Tan JMJ; Garner ME; Regeimbal JM; Greene CJ; Márquez JDR; Ammendolia DA; McCluggage ARR; Li T; Wu KJ; Cemma M; Ostrowski PP; Raught B; Diamond MS; Grinstein S; Yates RM; Higgins DE; Brumell JH
    Nat Commun; 2021 Aug; 12(1):4999. PubMed ID: 34404769
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular Mechanisms of Mast Cell Activation by Cholesterol-Dependent Cytolysins.
    Draberova L; Tumova M; Draber P
    Front Immunol; 2021; 12():670205. PubMed ID: 34248949
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Systemic and Cellular Metabolic Phenotype of Infection and Immune Response to
    Johnson RM; Olatunde AC; Woodie LN; Greene MW; Schwartz EH
    Front Immunol; 2020; 11():614697. PubMed ID: 33628207
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interaction of Macrophages and Cholesterol-Dependent Cytolysins: The Impact on Immune Response and Cellular Survival.
    Thapa R; Ray S; Keyel PA
    Toxins (Basel); 2020 Aug; 12(9):. PubMed ID: 32825096
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    Matereke LT; Okoh AI
    Pathogens; 2020 Jun; 9(7):. PubMed ID: 32629911
    [No Abstract]   [Full Text] [Related]  

  • 77. Pre-existing antibody-mediated adverse effects prevent the clinical development of a bacterial anti-inflammatory protein.
    Tromp AT; Zhao Y; Jongerius I; Heezius ECJM; Abrial P; Ruyken M; van Strijp JAG; de Haas CJC; Spaan AN; van Kessel KPM; Henry T; Haas PA
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32471891
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Beneficial Effect of Eco-Friendly Green Nanoparticles Using
    Alkhuriji AF; Majrashi NA; Alomar S; El-Khadragy MF; Awad MA; Khatab AR; Yehia HM
    Animals (Basel); 2020 Mar; 10(4):. PubMed ID: 32235366
    [No Abstract]   [Full Text] [Related]  

  • 79. Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat.
    Ali S; Mann-Nüttel R; Schulze A; Richter L; Alferink J; Scheu S
    Front Immunol; 2019; 10():778. PubMed ID: 31031767
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The probacterial effect of type I interferon signaling requires its own negative regulator USP18.
    Shaabani N; Honke N; Nguyen N; Huang Z; Arimoto KI; Lazar D; Loe TK; Lang KS; Prinz M; Knobeloch KP; Zhang DE; Teijaro JR
    Sci Immunol; 2018 Sep; 3(27):. PubMed ID: 30266866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.